In a rat diabetic model, treatment with a JAK-STAT inhibitor (AG-490) reduced proteinuria (Banes et al., 2004); and overexpression of JAK2 in diabetic mouse podocytes elevated JAK-STAT pathway activity and exacerbated diabetic kidney disease (Zhang et al., 2017). Here, JAK2 is linked to diabetic kidney disease.